These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8454375)

  • 1. Cardiocytolytic antimyolemmal antibodies in dilated cardiomyopathy following presentation: observations in 7 patients.
    Taha TH; Mazeika PK; Oakley CM; Maisch B
    Int J Cardiol; 1993 Feb; 38(2):133-40. PubMed ID: 8454375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic regulator and effector functions in perimyocarditis, postmyocarditic heart muscle disease and dilated cardiomyopathy.
    Maisch B
    Basic Res Cardiol; 1986; 81 Suppl 1():217-41. PubMed ID: 2947566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Humoral and cellular immunity in perimyocarditis and congestive cardiomyopathy].
    Maisch B; Kochsiek K
    Kardiologiia; 1985 Jun; 25(6):95-102. PubMed ID: 2995721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy.
    Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S
    G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy.
    Maisch B; Deeg P; Liebau G; Kochsiek K
    Am J Cardiol; 1983 Nov; 52(8):1072-8. PubMed ID: 6356861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are antisarcolemmal (ASAs) and antimyolemmal antibodies (AMLAs) "natural" antibodies?
    Maisch B; Drude L; Hengstenberg C; Herzum M; Hufnagel G; Kochsiek K; Schmaltz A; Schönian U; Schwab MD
    Basic Res Cardiol; 1991; 86 Suppl 3():101-14. PubMed ID: 1664204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four years of experience in endomyocardial biopsy--an immunohistologic approach.
    Maisch B; Büschel G; Izumi T; Eigel P; Regitz V; Deeg P; Pfeifer U; Schmaltz A; Herzum M; Liebau G
    Heart Vessels Suppl; 1985; 1():59-67. PubMed ID: 3916479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytolytic anticardiac membrane antibodies in the pathogenesis of myopericarditis.
    Maisch B; Drude L; Hengstenberg C; Hufnagel G; Schönian U; Schwab D
    Postgrad Med J; 1992; 68 Suppl 1():S11-6. PubMed ID: 1409209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticardiac antibodies in hypertrophic cardiomyopathy as a marker of severity.
    Maisch B
    Postgrad Med J; 1992; 68 Suppl 1():S29-35. PubMed ID: 1409212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis. Characterization and pathogenetic relevance.
    Maisch B; Bauer E; Cirsi M; Kochsiek K
    Circulation; 1993 May; 87(5 Suppl):IV49-65. PubMed ID: 8485834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rickettsial perimyocarditis--a follow-up study.
    Maisch B
    Heart Vessels; 1986; 2(1):55-9. PubMed ID: 3522535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic regulator and effector mechanisms in myocarditis and perimyocarditis.
    Maisch B
    Heart Vessels Suppl; 1985; 1():209-17. PubMed ID: 2956237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically determined myocarditis: clinical presentation and immunological characteristics.
    Caforio AL; Iliceto S
    Curr Opin Cardiol; 2008 May; 23(3):219-26. PubMed ID: 18382209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy.
    Caforio AL; Bonifacio E; Stewart JT; Neglia D; Parodi O; Bottazzo GF; McKenna WJ
    J Am Coll Cardiol; 1990 Jun; 15(7):1527-34. PubMed ID: 2188986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential diagnosis and prognosis of primary and post-myocarditis cardiomyopathy in childhood].
    Schmaltz AA; Sieverding L; Apitz J; Maisch B; Hort W
    Wien Klin Wochenschr; 1988 Dec; 100(24):811-3. PubMed ID: 3070966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ-specific cardiac autoantibodies in dilated cardiomyopathy. Frequency and clinical correlates in Polish patients.
    Bilińska ZT; Caforio AL; Grzybowski J; Michalak E; Kuśmierczyk-Droszcz B; Goldman JH; Haven AJ; Rydlewska-Sadowska W; McKenna WJ; Ruzyłło W
    Eur Heart J; 1995 Dec; 16(12):1907-11. PubMed ID: 8682025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired myocyte function in vitro incubated with sera from patients with myocarditis.
    Drude L; Wiemers F; Maisch B
    Eur Heart J; 1991 Aug; 12 Suppl D():36-8. PubMed ID: 1915457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression.
    Caforio AL; Goldman JH; Baig MK; Haven AJ; Dalla Libera L; Keeling PJ; McKenna WJ
    Heart; 1997 Jan; 77(1):62-7. PubMed ID: 9038697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy].
    Lauer B; Padberg K; Schultheiss HP; Strauer BE
    Z Kardiol; 1995 Apr; 84(4):301-10. PubMed ID: 7785303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting.
    Latif N; Baker CS; Dunn MJ; Rose ML; Brady P; Yacoub MH
    J Am Coll Cardiol; 1993 Nov; 22(5):1378-84. PubMed ID: 7901255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.